| Literature DB >> 36035727 |
Michael Gutensohn1, Erin Hartzell1, Natalia Dudareva2,3,4.
Abstract
Terpenoids constitute one of the largest and most diverse classes of plant metabolites. While some terpenoids are involved in essential plant processes such as photosynthesis, respiration, growth, and development, others are specialized metabolites playing roles in the interaction of plants with their biotic and abiotic environment. Due to the distinct functions and properties of specific terpenoid compounds, there is a growing interest to introduce or modify their production in plants by metabolic engineering for agricultural, pharmaceutical, or industrial applications. The MVA and MEP pathways and the prenyltransferases providing the general precursors for terpenoid formation, as well as the enzymes of the various downstream metabolic pathways leading to the formation of different groups of terpenoid compounds have been characterized in detail in plants. In contrast, the molecular mechanisms directing the metabolic flux of precursors specifically toward one of several potentially competing terpenoid biosynthetic pathways are still not well understood. The formation of metabolons, multi-protein complexes composed of enzymes catalyzing sequential reactions of a metabolic pathway, provides a promising concept to explain the metabolic channeling that appears to occur in the complex terpenoid biosynthetic network of plants. Here we provide an overview about examples of potential metabolons involved in plant terpenoid metabolism that have been recently characterized and the first attempts to utilize metabolic channeling in terpenoid metabolic engineering. In addition, we discuss the gaps in our current knowledge and in consequence the need for future basic and applied research.Entities:
Keywords: chlorophyll; membrane complexes; metabolic channeling; metabolic engineering; metabolons; prenyltransferases; sterols; terpenoids
Year: 2022 PMID: 36035727 PMCID: PMC9399743 DOI: 10.3389/fpls.2022.954083
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 6.627
FIGURE 1The plant terpenoid metabolic network and potential metabolons involved in the biosynthesis of specific compounds. The plastid and endoplasmic reticulum are highlighted in green and purple, respectively. The MVA pathway enzymes localized in peroxisomes and the cytosol are labeled in blue and orange, respectively. Individual enzymes are depicted as boxes and black arrows indicate metabolic fluxes. Confirmed and putative (with question mark) interactions of prenyltransferases with downstream enzymes forming metabolons are indicated by red arrows. The unknown transporter involved in IPP and DMAPP exchange between cytosol and plastid is shown in the plastid envelope membrane. Abbreviations: AACT, aceto-acetyl-CoA thiolase; CHLG, chlorophyll synthase; CMK, 4-(cytidine 5-diphospho)-2-C-methyl-D-erythritol kinase; CPQ, cucurbitadienol synthase; CSD, sterol C-3 dehydrogenase/C-4 decarboxylase; DMAPP, dimethylallyl diphosphate; DXR, 1-deoxy-D-xylulose 5-phosphate reductoisomerase; DXS, 1-deoxy-D-xylulose 5-phosphate synthase; FPPS, farnesyl diphosphate synthase; GA-3P, D-glyceraldehyde 3-phosphate; GGPPS, geranylgeranyl diphosphate synthase; GGR, geranylgeranyl reductase; GPPS, geranyl diphosphate synthase; GRP, GGPPS recruiting protein; HDR, (E)-4-hydroxy-3-methylbut-2-enyl diphosphate reductase; HDS, (E)-4-hydroxy-3-methylbut-2-enyl diphosphate synthase; HMGR, 3-hydroxy-3-methylglutaryl-CoA reductase; HMGS, 3-hydroxy-3-methylglutaryl-CoA synthase; IDI, isopentenyl diphosphate isomerase; IPP, isopentenyl diphosphate; LIL3; light-harvesting-like protein 3; MCT, 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase; MDD, mevalonate diphosphate decarboxylase; MDS, 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase; MK, mevalonate kinase; PMK, phosphomevalonate kinase; PORB, protochlorophyllide oxidoreductase; PSY, phytoene synthase; SKR, sterol C-3 keto-reductase; SMO, sterol C-4 methyl oxidase; SPS, solanesyl diphosphate synthase; SQE, squalene epoxidase; SQS, squalene synthase; TPS, terpene synthases (including mono- and sesquiterpene synthases).
FIGURE 2Engineering approaches utilizing metabolic channeling for improved terpenoid formation. (A) Enzyme fusion strategy: fusion of prenyltransferases (GGPPS, FPPS) with phytoene synthase (PSY) and terpene synthases (epi-aristolochene synthase EAS, amorpha-4,11-diene synthase ADS), respectively, leads to increased substrate (IPP, DMAPP) conversion to product formation. (B) Synthetic scaffold protein strategy: scaffold proteins carry multiple protein-protein interaction domains (GBD, SH3, PDZ) in various ratios (x: y: z) to organize multiple sequential pathway enzymes (e.g., AACT, HMGS, HMGR) tagged with specific small peptide ligands (indicated by a square, triangle and circle) to increase metabolic flux through a pathway. (C) Lipid droplet strategy: engineered cytosolic lipid droplets serve as scaffold to co-localize terpenoid biosynthetic enzymes, e.g., diterpene synthase abietadiene synthase (ABS), cytochrome P450 (CYP), and cytochrome P450 reductase (CPR), that are expressed as fusion constructs with a lipid droplet surface protein (LDSP). It will result in increased production of terpenoid compounds (e.g., diterpenes) and additionally in their sequestration in the engineered lipid droplets.